MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Clinical trials for MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS trials appear
Sign up with your email to follow new studies for MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat stomach cancer: immune-boosting combo tested before surgery
Disease control Not yet recruitingThis study tests two different drug combinations given before surgery for people with a specific genetic type of stomach or gastroesophageal junction cancer (dMMR/MSI-H). The goal is to see if these combinations can completely eliminate the tumor before surgery. About 30 adults w…
Matched conditions: MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Scientists investigate why some stomach cancers shrink with immunotherapy and others Don't
Knowledge-focused Not yet recruitingThis study looks at a specific type of stomach cancer (dMMR/MSI-H) that often responds well to immunotherapy, but about half of patients do not benefit. Researchers will treat 15 people with immunotherapy before surgery to see who has a complete response and study why some tumors…
Matched conditions: MISMATCH REPAIR DEFICIENT OR MSI-HIGH SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:39 UTC